Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Rovesti

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Annals of Translational Medicine|November 4, 2020
Child Pugh and ALBI grade: past, present or future?Margherita Rimini, Giulia Rovesti, Andrea Casadei-Gardini
Cancers|January 22, 2021
Recent Research on Gastrointestinal CarcinomaGiulia Rovesti, Giorgia Marisi, Andrea Casadei-Gardini
Cancers|November 17, 2020
BRCA in Gastrointestinal Cancers: Current Treatments and Future PerspectivesEleonora Molinaro, Kalliopi Andrikou, Andrea Casadei-Gardini, et al.
Pharmaceuticals (Basel, Switzerland)|January 12, 2021
The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A ReviewFrancesca Matilde Schipilliti, Ingrid Garajová, Giulia Rovesti, et al.
Cancers|September 10, 2021
Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for ImmunotherapyPanagiota Maravelia, Daniela Nascimento Silva, Giulia Rovesti, et al.
Nutrients|October 23, 2021
Clinical Implications of Malnutrition in the Management of Patients with Pancreatic Cancer: Introducing the Concept of the Nutritional Oncology BoardGiulia Rovesti, Filippo Valoriani, Margherita Rimini, et al.
Cancer Gene Therapy|June 30, 2018
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapyFilippo Rossignoli, Giulia Grisendi, Carlotta Spano, et al.
Journal of Hepatology|August 27, 2019
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patientsFrancesco Tovoli, Luca Ielasi, Andrea Casadei-Gardini, et al.
Clinical Colorectal Cancer|March 21, 2020
Is There an Optimal Choice in Refractory Colorectal Cancer? A Network Meta-AnalysisAndrea Casadei-Gardini, Alessandro Vagheggini, Fabio Gelsomino, et al.
Therapeutic Advances in Medical Oncology|October 16, 2020
Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trialAndrea Casadei Gardini, Emanuela Scarpi, Martina Valgiusti, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Annals of Translational Medicine|November 4, 2020
Child Pugh and ALBI grade: past, present or future?Margherita Rimini, Giulia Rovesti, Andrea Casadei-Gardini
Cancers|January 22, 2021
Recent Research on Gastrointestinal CarcinomaGiulia Rovesti, Giorgia Marisi, Andrea Casadei-Gardini
Cancers|November 17, 2020
BRCA in Gastrointestinal Cancers: Current Treatments and Future PerspectivesEleonora Molinaro, Kalliopi Andrikou, Andrea Casadei-Gardini, et al.
Pharmaceuticals (Basel, Switzerland)|January 12, 2021
The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A ReviewFrancesca Matilde Schipilliti, Ingrid Garajová, Giulia Rovesti, et al.
Cancers|September 10, 2021
Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for ImmunotherapyPanagiota Maravelia, Daniela Nascimento Silva, Giulia Rovesti, et al.
Nutrients|October 23, 2021
Clinical Implications of Malnutrition in the Management of Patients with Pancreatic Cancer: Introducing the Concept of the Nutritional Oncology BoardGiulia Rovesti, Filippo Valoriani, Margherita Rimini, et al.
Cancer Gene Therapy|June 30, 2018
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapyFilippo Rossignoli, Giulia Grisendi, Carlotta Spano, et al.
Journal of Hepatology|August 27, 2019
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patientsFrancesco Tovoli, Luca Ielasi, Andrea Casadei-Gardini, et al.
Clinical Colorectal Cancer|March 21, 2020
Is There an Optimal Choice in Refractory Colorectal Cancer? A Network Meta-AnalysisAndrea Casadei-Gardini, Alessandro Vagheggini, Fabio Gelsomino, et al.
Therapeutic Advances in Medical Oncology|October 16, 2020
Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trialAndrea Casadei Gardini, Emanuela Scarpi, Martina Valgiusti, et al.
Pageof 4